Results 31 to 40 of about 269 (119)

Dispute Settlement in the Law of the Sea:Survey for 2022 [PDF]

open access: yes, 2023
This is the latest in a series of annual surveys in this Journal reviewing dispute settlement in the law of the sea, both under Part XV of the UN Convention on the Law of the Sea and outside the framework of the Convention.
Churchill, Robin
core   +2 more sources

2547 Long-term response to treatment and disease recurrence in a prospective cohort of morphea patients

open access: yesJournal of Clinical and Translational Science, 2018
OBJECTIVES/SPECIFIC AIMS: Morphea (localized scleroderma) is an autoimmune disease characterized that is widely thought to have a monophasic course, in which an initial period of inflammation (activity) ultimately results in scarring, atrophy, and ...
Stephanie Florez-Pollack   +2 more
doaj   +1 more source

Prior elicitation of the efficacy and tolerability of Methotrexate and Mycophenolate Mofetil in Juvenile Localised Scleroderma [PDF]

open access: yes, 2021
BackgroundEvidence is lacking for safe and effective treatments for juvenile localised scleroderma (JLS). Methotrexate (MTX) is commonly used first line and mycophenolate mofetil (MMF) second line, despite a limited evidence base. A head to head trial of
Anderson, Marina E   +20 more
core  

Sclerosing diseases of the skin

open access: yesJDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 23, Issue 10, Page 1282-1301, October 2025.
Summary Sclerosing skin diseases comprise a group of distinct dermatological conditions characterized by fibrotic changes that may severely impair patients’ quality of life. These conditions often present with cutaneous manifestations and, in some cases, may extend to extracutaneous tissues, potentially resulting in significant morbidity and mortality.
Yasamin Kalantari   +4 more
wiley   +1 more source

Sklerosierende Erkrankungen der Haut

open access: yesJDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 23, Issue 10, Page 1282-1303, October 2025.
Zusammenfassung Sklerosierende Hautkrankheiten sind eine Gruppe unterschiedlicher dermatologischer Erkrankungen, die durch fibrotische Veränderungen gekennzeichnet sind und die Lebensqualität der Patienten stark einschränken können. Diese Erkrankungen treten häufig mit kutanen Manifestationen auf und können in bestimmten Fällen auch extrakutanes Gewebe
Yasamin Kalantari   +4 more
wiley   +1 more source

Efficacy and Safety of Ablative Fractional CO2 Laser Therapy for Localized Scleroderma: A Comprehensive Bench‐to‐Bedside Approach

open access: yesDermatologic Therapy, Volume 2025, Issue 1, 2025.
Background Localized scleroderma (LS) is a disfiguring chronic inflammatory disease characterized by fibrosis of the skin and subcutaneous tissue. As the available therapeutic options are limited, developing effective and safe treatment protocols is crucial. Methods This study included both animal experiments and a single‐arm, open‐label clinical trial.
Ke Chai   +17 more
wiley   +1 more source

Magnetic Resonance Imaging Evaluation in Patients with Linear Morphea Treated with Methotrexate and High‐Dose Corticosteroid

open access: yesDermatology Research and Practice, Volume 2018, Issue 1, 2018., 2018
Background. Morphea is an inflammatory disease of the connective tissue that may lead to thickening and hardening of the skin due to fibrosis. The aim of this study was to document magnetic resonance imaging (MRI) changes in patients with linear morphea who were treated with methotrexate (MTX) and high‐dose corticosteroid. Methods.
Mohammad Shahidi-Dadras   +6 more
wiley   +1 more source

Comparison of 3D facial photographs and clinical documentation in patients with craniofacial morphea

open access: yesSkin Health and Disease, Volume 4, Issue 6, December 2024.
Craniofacial morphea (CM) is a rare autoimmune disease characterised by progressive atrophy of the skin and soft tissue of the face, resulting in facial asymmetry. With the involvement of varying practices in the care of patients with CM, consistent documentation of disease location and severity lack standardized evaluation.
Tyler T. Nguyen   +5 more
wiley   +1 more source

S2k guideline: Diagnosis and therapy of localized scleroderma

open access: yesJDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 22, Issue 4, Page 605-620, April 2024.
Summary The updated S2k guideline deals with the diagnosis and therapy of localized scleroderma (LoS). LoS represents a spectrum of sclerotic skin diseases in which, depending on the subtype and localisation, structures such as adipose tissue, muscles, joints, and bones may also be affected.
Alexander Kreuter   +12 more
wiley   +1 more source

Unravelling morphoea aetiopathogenesis by next-generation sequencing of paired skin biopsies [PDF]

open access: yes, 2023
BACKGROUND: Morphoea can have a significant disease burden. Aetiopathogenesis remains poorly understood, with very limited existing genetic studies. Linear morphoea (LM) may follow Blascho's lines of epidermal development, providing potential pathogenic ...
Abraham, David J   +5 more
core  

Home - About - Disclaimer - Privacy